Stock

Atrium Therapeutics, Inc - Registered Shs

000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol RNA_NEW:xnas
Currency USD
united-states
NASDAQ
Open Closed
15 minutes delayed
Data provided by Cboe Global Markets
This information is not currently available for this instrument. Refresh the page or try again later.

Chart

This information is not currently available for this instrument. Refresh the page or try again later.
Open account to access more charting and analysis tools

Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer

About Atrium Therapeutics, Inc - Registered Shs

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Sector -
Industry -
Market cap -
Data provided by Morningstar / FactSet Research Systems

Others were interested in

This information is not currently available for this instrument. Refresh the page or try again later.
See all stocks

Frequently asked questions

To buy Atrium Therapeutics, Inc - Registered Shs stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Atrium Therapeutics, Inc - Registered Shs by name or ticker, choose the number of shares, and place your order.

Learn about Saxo accounts.

The ticker symbol for Atrium Therapeutics, Inc - Registered Shs is RNA_NEW:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.

Atrium Therapeutics, Inc - Registered Shs has its primary listing on NASDAQ. You can trade Atrium Therapeutics, Inc - Registered Shs with a Saxo account, alongside thousands of other stocks worldwide.

Yes, Atrium Therapeutics, Inc - Registered Shs is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Atrium Therapeutics, Inc - Registered Shs as part of a broader investment portfolio.

Explore our SaxoInvestor platform.

Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Atrium Therapeutics, Inc - Registered Shs or others.

Saxo Bank A/S (Headquarters)
Philip Heymans Alle 15
2900 Hellerup
Denmark

Contact Saxo

International
International

All trading and investing comes with risk, including but not limited to the potential to lose your entire invested amount.

Information on our international website (as selected from the globe drop-down) can be accessed worldwide and relates to Saxo Bank A/S as the parent company of the Saxo Bank Group. Any mention of the Saxo Bank Group refers to the overall organisation, including subsidiaries and branches under Saxo Bank A/S. Client agreements are made with the relevant Saxo entity based on your country of residence and are governed by the applicable laws of that entity's jurisdiction.

Apple and the Apple logo are trademarks of Apple Inc., registered in the US and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.